bioRxivMicrobiology
The Chlamydia trachomatis type III secreted effector protein CteG induces centrosome amplification through interactions with centrin-2
B. Steiert, C. Icardi, R. Faris, A. J. Klingelhutz, P. Yau, M. M. Weber
Abstract
The centrosome is the main microtubule organizing center of the cell and is crucial for mitotic spindle assembly, chromosome segregation, and cell division. Centrosome duplication is tightly controlled, yet several pathogens, most notably oncogenic viruses, perturb this process leading to increased centrosome numbers. Infection by the obligate intracellular pathogen Chlamydia trachomatis (C.t.) correlates with blocked cytokinesis, supernumerary centrosomes, and multipolar spindles; however, the mechanisms behind how C.t. induces these cellular abnormalities from the confines of its inclusion, remain largely unknown. Here we show that the type III secreted effector protein, CteG, binds to centrin-2 (CETN2), a key structural component of centrosomes and regulator of centriole duplication. This interaction requires a functional calcium binding EF hand 4 of CETN2, which is recognized via the C-terminus of CteG. Significantly, we show that deletion of CteG, or knockdown of CETN2, significantly impairs chlamydias ability to induce centrosome amplification. Uniquely, we have identified the first bacterial effector to target centrins, crucial regulators of the eukaryotic cell cycle. These findings have not only allowed us to begin addressing how C.t. induces gross cellular abnormalities during infection, but also indicate that obligate intracellular bacteria may contribute to cellular transformation events that negatively impact host physiology even when the pathogen is long removed. Understanding the consequences of CteG-CETN2 interactions, its impact on centrosome amplification, and the long-term effect this has on host cells could explain why chlamydial infection leads to an increased risk of cervical or ovarian cancer. Significance StatementThe presence of more than two centrosomes is a hallmark of many types of cancer, including cervical and ovarian cancers of which Chlamydia trachomatis (C.t.) infection is a significant risk factor. Despite the importance of this problem, how C.t. orchestrates these drastic changes in the host cell remains poorly understood. Here, we describe how C.t. uses a single effector protein, CteG, to drive centrosome amplification via manipulation of a key regulator of centriole duplication, centrin-2. This work begins to define how C.t. induces centrosome amplification to promote its replication while potentially contributing to devastating long-term negative consequences for normal host physiology. Further it may help elucidate why chlamydial infection leads to an increased cancer risk.
- assay: proteomics
- research focus: cell signaling & trafficking
- research focus: cancer & tumor microenvironment
- research focus: host-pathogen & immune response
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Chlamydia trachomatis effector Dre1 interacts with dynactin to reposition host organelles during infection
- Chlamydia trachomatis TmeA promotes pedestal formation through N-WASP and TOCA-1 interactions
Alix McCullough, C.A. Jabeena, … Mary M. Weber·mSpherePeer-reviewed·Apr 15, 2025
- The Chlamydia trachomatis secreted effector CebN targets nucleoporins and Rae1 to antagonize STAT1 nuclear import
Brianna P. Steiert, Cherilyn A. Elwell, … Mary M. Weber·bioRxiv·Apr 25, 2024
- The effector TepP mediates the recruitment and activation of Phosphoinositide 3 Kinase on early Chlamydia trachomatis vacuoles
V. Carpenter, Y.-S. Chen, … R. Valdivia·bioRxiv·May 1, 2017
- Cell Type Development in Chlamydia trachomatis Follows a Program Intrinsic to the Reticulate Body.
T. J. Chiarelli, N. Grieshaber, … S. S. Grieshaber·bioRxiv·Mar 13, 2020
- Chlamydia trachomatis infection upregulates MicroRNA21 to deplete tumor suppressor PTEN
Karthika Rajeeve, Suvagata Roy Chowdhury, … Thomas Rudel·bioRxiv·May 12, 2026